LEQSELVI
NDC 47335-108, deuruxolitinib phosphate, tablet, film coated, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 47335-108
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217900
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47335-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEURUXOLITINIB PHOSPHATE8 mg/1
Pharmacologic classes
Bile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]; Organic Anion Transporter 3 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47335-108-86 | 47335010886 | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (47335-108-86) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a603f231-d09e-4bad-ad5e-b55f865da095
Use it
Look up 47335-108 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47335-108 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47335-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.